Tirzepatide injection technique: what TikTok gets right and wrong

What did @emagreacomsaude271 actually say?

Honestly? Very little that's decipherable. The transcript for this 922,000-view video is nearly incoherent, filled with phrases like "the best place to grow" repeated several times, references to a "Uteca area," and what appears to be an auto-generated or badly mistranslated caption from Portuguese. The creator is Brazilian, based in Mococa and São José do Rio Pardo, and the caption says "Applying tirzepatide without waste and efficiently." That's the actual claim here, buried in a caption rather than in any extractable spoken content.

So the real subject is injection technique for tirzepatide. The video likely demonstrates self-injection, which is a legitimate and common topic for people using GLP-1/GIP receptor agonists like tirzepatide (sold as Mounjaro for diabetes and Zepbound for weight management). Without a reliable transcript, we're fact-checking the implied claim: that there is a specific technique to inject tirzepatide "without waste and efficiently."

Does the science back this up?

Yes, actually, injection technique does matter for subcutaneous drug delivery, and this is an underappreciated topic in GLP-1 content. The general principle is sound, even if we can't verify the specifics shown.

Tirzepatide is administered as a subcutaneous injection, typically in the abdomen, thigh, or upper arm. Waste during self-injection is a real concern, particularly with prefilled pens that contain a fixed dose. A 2022 review by Frid et al. in Diabetes Therapy found that injection technique errors, including failure to prime the pen, injecting into inappropriate tissue, and improper needle angle, are associated with suboptimal drug absorption and dose variability. For a medication dosed weekly at precise amounts (2.5 mg through 15 mg increments), technique consistency is not trivial.

Additionally, patients using compounded tirzepatide, which is common in Brazil given access and cost considerations, may use vials and syringes rather than pens, making technique even more consequential for accurate dosing. There is no published data specifically on waste reduction techniques for tirzepatide self-injection, but the pharmacokinetic literature supports that subcutaneous delivery requires consistent depth and site rotation.

What did they get wrong (or right)?

We can't assess what the creator got wrong or right in terms of spoken content because the transcript is unusable. This is a significant limitation. The auto-transcription appears to have failed entirely, possibly because the video is in Portuguese and the tool attempted English transcription. That matters for fact-checking purposes because viral injection technique videos can spread genuinely dangerous practices.

What we can say: the framing in the caption, "without waste and efficiently," is a reasonable goal for anyone self-injecting a weekly peptide. If the video shows standard pen technique, rotating injection sites, pinching skin for lean individuals, or drawing from a vial accurately, those would be mostly accurate. If it showed reusing needles, injecting into muscle rather than subcutaneous tissue, or skipping priming steps, those would be problems worth flagging. We simply cannot confirm either way.

The broader concern here is that nearly one million people watched this video with no clinical context, no dosing guidance disclaimer, and no mention of medical supervision. That's a pattern in the Brazilian tirzepatide content ecosystem that deserves scrutiny.

What should you actually know?

Tirzepatide is a dual GIP and GLP-1 receptor agonist approved by the FDA in 2022 (Mounjaro) and 2023 (Zepbound). It is not a compounded peptide equivalent. Compounded versions of tirzepatide exist in various markets and are not bioequivalent to the branded product by regulatory definition. If you are using any version of tirzepatide, the following technique points are supported by evidence.

• Rotate injection sites each week. Using the same spot repeatedly causes lipohypertrophy, which impairs absorption. Frid et al. (2022, Diabetes Therapy) found site rotation compliance significantly affects glycemic outcomes in injectable therapies.
• For pen devices, always attach a new needle and perform the priming step before each injection to confirm pen function and remove air.
• Inject at a 90-degree angle for most patients. A 45-degree angle is appropriate only for very lean individuals injecting into the thigh.
• Do not share pens or needles. This is a bloodborne pathogen risk, not a preference.
• Any injection technique, regardless of how well-demonstrated on social media, should be confirmed with a prescribing clinician or pharmacist before first use.